Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Elena Verzoni, Giacomo Cartenì, Enrico Cortesi, Diana Giannarelli, Andrea De Giglio, Roberto Sabbatini, Sebastiano Buti, Sabrina Rossetti, Francesco Cognetti, Francesca Rastelli, Alberto Sobrero, Daniele Turci, Cora N Sternberg, Camillo Porta, Federico Cappuzzo, Giampaolo Tortora, Davide Tassinari, Stefano Panni, Antonio Pazzola, Gianmarco Surico, Alessandra Raimondi, Ugo De Giorgi, Giuseppe Procopio

ABSTRACT

BACKGROUND: The Italian Renal Cell Cancer Early Access Program was an expanded access program that allowed access to nivolumab, for patients (pts) with metastatic renal cell carcinoma (mRCC) prior to regulatory approval. METHODS: Pts with previously treated advanced or mRCC were eligible to receive nivolumab 3 mg/kg every 2 weeks. Pts included in the analysis had received ≥1 dose of nivolumab and were monitored for drug-related adverse events (drAEs) using CTCAE v.4.0. Immune-related (ir) AEs were defined as AEs displaying a certain, likely or possible correlation with immunotherapy (cutaneous, endocrine, hepatic, gastro-intestinal and pulmonary). The association between overall survival (OS) and irAEs was assessed, and associations between variables were evaluated with a logistic regression model. RESULTS: A total of 389 pts were enrolled between July 2015 and April 2016. Overall, the objective response rate was 23.1%. At a median follow-up of 12 months, the median progression-free survival was 4.5 months (95% CI 3.7-6.2) and the 12-month overall survival rate was 63%. Any grade and grade 3-4 drAEs were reported in 124 (32%) and 27 (7%) of pts, respectively, and there were no treatment-related deaths. Any grade irAEs occurred in 76 (20%) of patients, 8% cutaneous, 4% endocrine, 2% hepatic, 5% gastro-intestinal and 1% pulmonary. Of the 22 drAEs inducing treatment discontinuation, 10 (45%) were irAEs. Pts with drAEs had a significantly longer survival than those without drAEs (median OS 22.5 versus 16.4 months, p = 0.01). Pts with irAEs versus without irAEs had a more significant survival benefit (median OS not reached versus 16.8 months, p = 0.002), confirmed at the landmark analysis at 6 weeks. The occurrence of irAEs displayed a strong association with OS in univariable (HR 0.48, p = 0.003) and multivariable (HR 0.57, p = 0.02) analysis. CONCLUSIONS: The appearance of irAEs strongly correlates with survival benefit in a real-life population of mRCC pts treated with nivolumab. More... »

PAGES

99

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40425-019-0579-z

DOI

http://dx.doi.org/10.1186/s40425-019-0579-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1113181867

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30944023


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Medical Oncology-Genitourinary Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy. elena.verzoni@istitutotumori.mi.it."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Verzoni", 
        "givenName": "Elena", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Antonio Cardarelli", 
          "id": "https://www.grid.ac/institutes/grid.413172.2", 
          "name": [
            "Oncology Unit, A. Cardarelli Hospital, Naples, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carten\u00ec", 
        "givenName": "Giacomo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Policlinico Umberto I", 
          "id": "https://www.grid.ac/institutes/grid.417007.5", 
          "name": [
            "Radiology, Oncology and Pathology, Policlinico Umberto I, Rome, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cortesi", 
        "givenName": "Enrico", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituti Fisioterapici Ospitalieri", 
          "id": "https://www.grid.ac/institutes/grid.417520.5", 
          "name": [
            "Biostatistical Unit, Regina Elena National Cancer Institute - IRCCS, Rome, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giannarelli", 
        "givenName": "Diana", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera S.Maria", 
          "id": "https://www.grid.ac/institutes/grid.416377.0", 
          "name": [
            "Medical Oncology, Azienda Ospedaliera Santa Maria, Terni, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Giglio", 
        "givenName": "Andrea", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Policlinico di Modena", 
          "id": "https://www.grid.ac/institutes/grid.413363.0", 
          "name": [
            "Oncology and Hematology Department, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sabbatini", 
        "givenName": "Roberto", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale di Parma", 
          "id": "https://www.grid.ac/institutes/grid.411482.a", 
          "name": [
            "Medical Oncology, Azienda Ospedaliera di Parma, Parma, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Buti", 
        "givenName": "Sebastiano", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Urology and Gynecology, Istituto Nazionale Tumori - IRCCS - Fondazione Pascale, Naples, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rossetti", 
        "givenName": "Sabrina", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituti Fisioterapici Ospitalieri", 
          "id": "https://www.grid.ac/institutes/grid.417520.5", 
          "name": [
            "Medical Oncology, Regina Elena National Cancer Institute - IRCCS, Rome, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cognetti", 
        "givenName": "Francesco", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Medical Oncology, UOC Oncologia Area Vasta 4, Fermo, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rastelli", 
        "givenName": "Francesca", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale San Martino", 
          "id": "https://www.grid.ac/institutes/grid.410345.7", 
          "name": [
            "Medical Oncology, San Martino Hospital, Genoa, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sobrero", 
        "givenName": "Alberto", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria delle Croci", 
          "id": "https://www.grid.ac/institutes/grid.415207.5", 
          "name": [
            "Medical Oncology, Ospedale Santa Maria delle Croci, Ravenna, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Turci", 
        "givenName": "Daniele", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Medical Oncology, Azienda Ospedaliera S. Camillo Forlanini, Rome, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sternberg", 
        "givenName": "Cora N", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pavia", 
          "id": "https://www.grid.ac/institutes/grid.8982.b", 
          "name": [
            "Department of Internal Medicine, University of Pavia and Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Porta", 
        "givenName": "Camillo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Medical Oncology, Ospedale Umberto I (AUSL Romagna), Lugo, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cappuzzo", 
        "givenName": "Federico", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Medical Oncology, AOU Integrata Verona \"Borgo Roma\", Verona, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tortora", 
        "givenName": "Giampaolo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Infermi di Rimini", 
          "id": "https://www.grid.ac/institutes/grid.414614.2", 
          "name": [
            "Oncology, Ospedale Infermi, Rimini, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tassinari", 
        "givenName": "Davide", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituti Ospitalieri di Cremona", 
          "id": "https://www.grid.ac/institutes/grid.419450.d", 
          "name": [
            "Medical Oncology, Istituti Ospitalieri di Cremona, Cremona, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Panni", 
        "givenName": "Stefano", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Medical Oncology, Ospedale Civile SS Annunziata, Sassari, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pazzola", 
        "givenName": "Antonio", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Vito Fazzi", 
          "id": "https://www.grid.ac/institutes/grid.417011.2", 
          "name": [
            "Medical Oncology, Ospedale Vito Fazzi, Lecce, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Surico", 
        "givenName": "Gianmarco", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Medical Oncology-Genitourinary Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raimondi", 
        "givenName": "Alessandra", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Urologic-Gynecologic Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Giorgi", 
        "givenName": "Ugo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Medical Oncology-Genitourinary Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Procopio", 
        "givenName": "Giuseppe", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1097/cji.0000000000000046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006229006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0000000000000046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006229006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/17425255.2016.1214713", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006340760"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2015.60.8448", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009760042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e318156e47e", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015171108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e318156e47e", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015171108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamaoncol.2015.2274", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017475370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1510665", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019970557"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.06.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021025524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.06.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021025524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0053745", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032246329"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamadermatol.2015.1916", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032824188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2015.11.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034148114"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1200690", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042896583"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.57.4756", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043986240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-07-0187", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049037424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/2162402x.2016.1231292", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058420756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdw640", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059394941"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-15-1136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063224982"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2015.66.1389", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079388627"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.eururo.2017.02.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084074059"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.eururo.2017.02.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084074059"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2017-0133", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1086386152"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0000000000004359", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091248943"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0000000000004359", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091248943"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0000000000004359", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091248943"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jtho.2017.08.022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091880982"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3390/cancers10020032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100657075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2017.77.6385", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101034912"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2017-0384", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105038826"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bju.14461", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105203453"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2016.34.15_suppl.3047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106841583"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: The Italian Renal Cell Cancer Early Access Program was an expanded access program that allowed access to nivolumab, for patients (pts) with metastatic renal cell carcinoma (mRCC) prior to regulatory approval.\nMETHODS: Pts with previously treated advanced or mRCC were eligible to receive nivolumab 3\u2009mg/kg every 2\u2009weeks. Pts included in the analysis had received \u22651 dose of nivolumab and were monitored for drug-related adverse events (drAEs) using CTCAE v.4.0. Immune-related (ir) AEs were defined as AEs displaying a certain, likely or possible correlation with immunotherapy (cutaneous, endocrine, hepatic, gastro-intestinal and pulmonary). The association between overall survival (OS) and irAEs was assessed, and associations between variables were evaluated with a logistic regression model.\nRESULTS: A total of 389 pts were enrolled between July 2015 and April 2016. Overall, the objective response rate was 23.1%. At a median follow-up of 12\u2009months, the median progression-free survival was 4.5\u2009months (95% CI 3.7-6.2) and the 12-month overall survival rate was 63%. Any grade and grade 3-4 drAEs were reported in 124 (32%) and 27 (7%) of pts, respectively, and there were no treatment-related deaths. Any grade irAEs occurred in 76 (20%) of patients, 8% cutaneous, 4% endocrine, 2% hepatic, 5% gastro-intestinal and 1% pulmonary. Of the 22 drAEs inducing treatment discontinuation, 10 (45%) were irAEs. Pts with drAEs had a significantly longer survival than those without drAEs (median OS 22.5 versus 16.4\u2009months, p\u2009=\u20090.01). Pts with irAEs versus without irAEs had a more significant survival benefit (median OS not reached versus 16.8\u2009months, p\u2009=\u20090.002), confirmed at the landmark analysis at 6\u2009weeks. The occurrence of irAEs displayed a strong association with OS in univariable (HR 0.48, p\u2009=\u20090.003) and multivariable (HR 0.57, p\u2009=\u20090.02) analysis.\nCONCLUSIONS: The appearance of irAEs strongly correlates with survival benefit in a real-life population of mRCC pts treated with nivolumab.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s40425-019-0579-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1049249", 
        "issn": [
          "2051-1426"
        ], 
        "name": "Journal for ImmunoTherapy of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "name": "Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program.", 
    "pagination": "99", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40425-019-0579-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1113181867"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101620585"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30944023"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40425-019-0579-z", 
      "https://app.dimensions.ai/details/publication/pub.1113181867"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-15T09:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000375_0000000375/records_91444_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://jitc.biomedcentral.com/articles/10.1186/s40425-019-0579-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0579-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0579-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0579-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0579-z'


 

This table displays all metadata directly associated to this object as RDF triples.

325 TRIPLES      21 PREDICATES      54 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40425-019-0579-z schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N7834c761e8614e548018d36339b870c0
4 schema:citation https://doi.org/10.1001/jamadermatol.2015.1916
5 https://doi.org/10.1001/jamaoncol.2015.2274
6 https://doi.org/10.1016/j.ejca.2015.11.016
7 https://doi.org/10.1016/j.eururo.2017.02.010
8 https://doi.org/10.1016/j.jtho.2017.08.022
9 https://doi.org/10.1056/nejmoa1200690
10 https://doi.org/10.1056/nejmoa1510665
11 https://doi.org/10.1080/17425255.2016.1214713
12 https://doi.org/10.1080/2162402x.2016.1231292
13 https://doi.org/10.1093/annonc/mdw640
14 https://doi.org/10.1097/cji.0000000000000046
15 https://doi.org/10.1097/cji.0b013e318156e47e
16 https://doi.org/10.1111/bju.14461
17 https://doi.org/10.1158/1078-0432.ccr-07-0187
18 https://doi.org/10.1158/1078-0432.ccr-15-1136
19 https://doi.org/10.1200/jco.2005.06.205
20 https://doi.org/10.1200/jco.2014.57.4756
21 https://doi.org/10.1200/jco.2015.60.8448
22 https://doi.org/10.1200/jco.2015.66.1389
23 https://doi.org/10.1200/jco.2016.34.15_suppl.3047
24 https://doi.org/10.1200/jco.2017.77.6385
25 https://doi.org/10.1212/wnl.0000000000004359
26 https://doi.org/10.1371/journal.pone.0053745
27 https://doi.org/10.1634/theoncologist.2017-0133
28 https://doi.org/10.1634/theoncologist.2017-0384
29 https://doi.org/10.3390/cancers10020032
30 schema:datePublished 2019-12
31 schema:datePublishedReg 2019-12-01
32 schema:description BACKGROUND: The Italian Renal Cell Cancer Early Access Program was an expanded access program that allowed access to nivolumab, for patients (pts) with metastatic renal cell carcinoma (mRCC) prior to regulatory approval. METHODS: Pts with previously treated advanced or mRCC were eligible to receive nivolumab 3 mg/kg every 2 weeks. Pts included in the analysis had received ≥1 dose of nivolumab and were monitored for drug-related adverse events (drAEs) using CTCAE v.4.0. Immune-related (ir) AEs were defined as AEs displaying a certain, likely or possible correlation with immunotherapy (cutaneous, endocrine, hepatic, gastro-intestinal and pulmonary). The association between overall survival (OS) and irAEs was assessed, and associations between variables were evaluated with a logistic regression model. RESULTS: A total of 389 pts were enrolled between July 2015 and April 2016. Overall, the objective response rate was 23.1%. At a median follow-up of 12 months, the median progression-free survival was 4.5 months (95% CI 3.7-6.2) and the 12-month overall survival rate was 63%. Any grade and grade 3-4 drAEs were reported in 124 (32%) and 27 (7%) of pts, respectively, and there were no treatment-related deaths. Any grade irAEs occurred in 76 (20%) of patients, 8% cutaneous, 4% endocrine, 2% hepatic, 5% gastro-intestinal and 1% pulmonary. Of the 22 drAEs inducing treatment discontinuation, 10 (45%) were irAEs. Pts with drAEs had a significantly longer survival than those without drAEs (median OS 22.5 versus 16.4 months, p = 0.01). Pts with irAEs versus without irAEs had a more significant survival benefit (median OS not reached versus 16.8 months, p = 0.002), confirmed at the landmark analysis at 6 weeks. The occurrence of irAEs displayed a strong association with OS in univariable (HR 0.48, p = 0.003) and multivariable (HR 0.57, p = 0.02) analysis. CONCLUSIONS: The appearance of irAEs strongly correlates with survival benefit in a real-life population of mRCC pts treated with nivolumab.
33 schema:genre research_article
34 schema:inLanguage en
35 schema:isAccessibleForFree true
36 schema:isPartOf Na81f93f9986b46e0ae68c4d4279d59ed
37 Nb6d7b0a59cc64ad099408c4806ac48aa
38 sg:journal.1049249
39 schema:name Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program.
40 schema:pagination 99
41 schema:productId N00b7f4f2d9da40a896f34163a648c672
42 N8706828893c44adf9e56a23f9a2290ef
43 Nb67c20b81e874989bef5b862f5e36ada
44 Nd77e4b60bdd84e15b1c3a6a2a72921e4
45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113181867
46 https://doi.org/10.1186/s40425-019-0579-z
47 schema:sdDatePublished 2019-04-15T09:01
48 schema:sdLicense https://scigraph.springernature.com/explorer/license/
49 schema:sdPublisher N7da1ddcefd484e789d0eb6c03c88a3df
50 schema:url https://jitc.biomedcentral.com/articles/10.1186/s40425-019-0579-z
51 sgo:license sg:explorer/license/
52 sgo:sdDataset articles
53 rdf:type schema:ScholarlyArticle
54 N0080ba117ef5415ca67744c948b7e135 schema:name Medical Oncology, Azienda Ospedaliera S. Camillo Forlanini, Rome, Italy.
55 rdf:type schema:Organization
56 N00b7f4f2d9da40a896f34163a648c672 schema:name dimensions_id
57 schema:value pub.1113181867
58 rdf:type schema:PropertyValue
59 N010b10a0a0ac4e24a905f5a23fba25f9 schema:affiliation https://www.grid.ac/institutes/grid.417520.5
60 schema:familyName Cognetti
61 schema:givenName Francesco
62 rdf:type schema:Person
63 N0206b6ecc3e74a1890423038813b54b3 rdf:first N76c22d24b7fa43b9a712ccf92651f00f
64 rdf:rest N25adf70c44fc43e0a82c1ea18f7ba017
65 N0428952aa75b42289d4cf5efeeef84c3 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
66 schema:familyName Raimondi
67 schema:givenName Alessandra
68 rdf:type schema:Person
69 N049aa97d90f7470abec1a7f5012ce90b schema:affiliation https://www.grid.ac/institutes/grid.411482.a
70 schema:familyName Buti
71 schema:givenName Sebastiano
72 rdf:type schema:Person
73 N05776e345c59462ca6ceb8ef941cb4f6 schema:name Medical Oncology, Ospedale Civile SS Annunziata, Sassari, Italy.
74 rdf:type schema:Organization
75 N0f1a7f69354642b5b1d6c9bd6273e3d6 schema:affiliation N8bb91d5b960940f59c8d7cee743a8ea1
76 schema:familyName Tortora
77 schema:givenName Giampaolo
78 rdf:type schema:Person
79 N107d15ab432c4b428cd2e522c4e4f3ca schema:affiliation https://www.grid.ac/institutes/grid.413172.2
80 schema:familyName Cartenì
81 schema:givenName Giacomo
82 rdf:type schema:Person
83 N1edb2bdf62b644a7bdc33a1a577a0918 rdf:first N940695d762ed462297f94556d0dc1b95
84 rdf:rest Na805c4975eba4317b10d870f67e1f4ae
85 N216924dfa36e4b8a995aa21dc9a71147 rdf:first N010b10a0a0ac4e24a905f5a23fba25f9
86 rdf:rest N95b59ca9f0c840bcb4c0a517f2d77843
87 N25adf70c44fc43e0a82c1ea18f7ba017 rdf:first Nff2abd3b9e674bf8a02f3774c20732eb
88 rdf:rest N59656f5b89114389bbee27df4b94f020
89 N28894436c0264af4bb94b1052d3088ef rdf:first N87dc71984ce4483298a973602e930bff
90 rdf:rest N216924dfa36e4b8a995aa21dc9a71147
91 N2e1418df0570497db5f67a55a8c7ea91 schema:affiliation Ncc47b001a2db4caeb558eb52a291f80b
92 schema:familyName Rastelli
93 schema:givenName Francesca
94 rdf:type schema:Person
95 N36423f1eb22549f0ba52308cc93f889b rdf:first N0428952aa75b42289d4cf5efeeef84c3
96 rdf:rest Nb69179cc77b94e7aab54ece206125260
97 N3a46f2a8550a46538603c20af39aefbd schema:affiliation https://www.grid.ac/institutes/grid.417520.5
98 schema:familyName Giannarelli
99 schema:givenName Diana
100 rdf:type schema:Person
101 N3a74ef64e5a34d0fb0ec6a63c40940de schema:name Medical Oncology, Ospedale Umberto I (AUSL Romagna), Lugo, Italy.
102 rdf:type schema:Organization
103 N4a7d983516944b66b89859a0baf706e4 schema:affiliation https://www.grid.ac/institutes/grid.419450.d
104 schema:familyName Panni
105 schema:givenName Stefano
106 rdf:type schema:Person
107 N4ec432aedd0945a8a4c39191bc55d519 rdf:first Nf9d04f1a691b4eaf8c2b182e4f594dc5
108 rdf:rest N36423f1eb22549f0ba52308cc93f889b
109 N5827c46816424622a61e789a5c2439f1 schema:affiliation https://www.grid.ac/institutes/grid.414614.2
110 schema:familyName Tassinari
111 schema:givenName Davide
112 rdf:type schema:Person
113 N59656f5b89114389bbee27df4b94f020 rdf:first N0f1a7f69354642b5b1d6c9bd6273e3d6
114 rdf:rest N6644a8f5570f45c9b67f0e41209209b9
115 N6644a8f5570f45c9b67f0e41209209b9 rdf:first N5827c46816424622a61e789a5c2439f1
116 rdf:rest N851d07719479462a984877384119866d
117 N753daaa71ca54c24ba2c6431b7619865 rdf:first N7e9d276f77774aa4a6f618e9ebba3c84
118 rdf:rest Nbb8e4756030a464081cf5536397ce976
119 N76c22d24b7fa43b9a712ccf92651f00f schema:affiliation https://www.grid.ac/institutes/grid.8982.b
120 schema:familyName Porta
121 schema:givenName Camillo
122 rdf:type schema:Person
123 N7834c761e8614e548018d36339b870c0 rdf:first Ncb0f7c31d8c04548aebcd4ee634991e7
124 rdf:rest N9a19f0680f3a4c99b360e6cf91d437d0
125 N7da1ddcefd484e789d0eb6c03c88a3df schema:name Springer Nature - SN SciGraph project
126 rdf:type schema:Organization
127 N7e9d276f77774aa4a6f618e9ebba3c84 schema:affiliation https://www.grid.ac/institutes/grid.413363.0
128 schema:familyName Sabbatini
129 schema:givenName Roberto
130 rdf:type schema:Person
131 N8130b132de034af4b93533c0a1722c15 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
132 schema:familyName Procopio
133 schema:givenName Giuseppe
134 rdf:type schema:Person
135 N851d07719479462a984877384119866d rdf:first N4a7d983516944b66b89859a0baf706e4
136 rdf:rest Ne4bc6a11529f4c219f25e905bb0b87e1
137 N868becb0f89f466b8b15b062dfe81aa9 schema:affiliation https://www.grid.ac/institutes/grid.410345.7
138 schema:familyName Sobrero
139 schema:givenName Alberto
140 rdf:type schema:Person
141 N8706828893c44adf9e56a23f9a2290ef schema:name nlm_unique_id
142 schema:value 101620585
143 rdf:type schema:PropertyValue
144 N87dc71984ce4483298a973602e930bff schema:affiliation https://www.grid.ac/institutes/grid.417893.0
145 schema:familyName Rossetti
146 schema:givenName Sabrina
147 rdf:type schema:Person
148 N8bb91d5b960940f59c8d7cee743a8ea1 schema:name Medical Oncology, AOU Integrata Verona "Borgo Roma", Verona, Italy.
149 rdf:type schema:Organization
150 N8c36f83c0efc4d18a9a2853e23f1e2eb schema:affiliation https://www.grid.ac/institutes/grid.416377.0
151 schema:familyName De Giglio
152 schema:givenName Andrea
153 rdf:type schema:Person
154 N8e02baf2dc1f46bb998932c53dec3f6e rdf:first N868becb0f89f466b8b15b062dfe81aa9
155 rdf:rest Nf3216f7bb69b449299aa2ce5a0bc502d
156 N940695d762ed462297f94556d0dc1b95 schema:affiliation https://www.grid.ac/institutes/grid.417007.5
157 schema:familyName Cortesi
158 schema:givenName Enrico
159 rdf:type schema:Person
160 N95b59ca9f0c840bcb4c0a517f2d77843 rdf:first N2e1418df0570497db5f67a55a8c7ea91
161 rdf:rest N8e02baf2dc1f46bb998932c53dec3f6e
162 N9a19f0680f3a4c99b360e6cf91d437d0 rdf:first N107d15ab432c4b428cd2e522c4e4f3ca
163 rdf:rest N1edb2bdf62b644a7bdc33a1a577a0918
164 Na805c4975eba4317b10d870f67e1f4ae rdf:first N3a46f2a8550a46538603c20af39aefbd
165 rdf:rest Nbec8c54ba3254df2bf28713f47b16b4d
166 Na81f93f9986b46e0ae68c4d4279d59ed schema:volumeNumber 7
167 rdf:type schema:PublicationVolume
168 Nb4b2831f115d4d919f31b6a23d6ebb40 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
169 schema:familyName De Giorgi
170 schema:givenName Ugo
171 rdf:type schema:Person
172 Nb67c20b81e874989bef5b862f5e36ada schema:name pubmed_id
173 schema:value 30944023
174 rdf:type schema:PropertyValue
175 Nb69179cc77b94e7aab54ece206125260 rdf:first Nb4b2831f115d4d919f31b6a23d6ebb40
176 rdf:rest Ncd1812f73a8449e8887382977c0a298f
177 Nb6d7b0a59cc64ad099408c4806ac48aa schema:issueNumber 1
178 rdf:type schema:PublicationIssue
179 Nbb8e4756030a464081cf5536397ce976 rdf:first N049aa97d90f7470abec1a7f5012ce90b
180 rdf:rest N28894436c0264af4bb94b1052d3088ef
181 Nbd82f24e05bf4a44a05adc8a1d70cbdd schema:affiliation N0080ba117ef5415ca67744c948b7e135
182 schema:familyName Sternberg
183 schema:givenName Cora N
184 rdf:type schema:Person
185 Nbec8c54ba3254df2bf28713f47b16b4d rdf:first N8c36f83c0efc4d18a9a2853e23f1e2eb
186 rdf:rest N753daaa71ca54c24ba2c6431b7619865
187 Nc3e6412305de4204b09affda7ba94450 schema:affiliation https://www.grid.ac/institutes/grid.415207.5
188 schema:familyName Turci
189 schema:givenName Daniele
190 rdf:type schema:Person
191 Ncb0f7c31d8c04548aebcd4ee634991e7 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
192 schema:familyName Verzoni
193 schema:givenName Elena
194 rdf:type schema:Person
195 Ncc47b001a2db4caeb558eb52a291f80b schema:name Medical Oncology, UOC Oncologia Area Vasta 4, Fermo, Italy.
196 rdf:type schema:Organization
197 Ncd1812f73a8449e8887382977c0a298f rdf:first N8130b132de034af4b93533c0a1722c15
198 rdf:rest rdf:nil
199 Nd0c4b0379ca647808311387df028379d rdf:first Nbd82f24e05bf4a44a05adc8a1d70cbdd
200 rdf:rest N0206b6ecc3e74a1890423038813b54b3
201 Nd77e4b60bdd84e15b1c3a6a2a72921e4 schema:name doi
202 schema:value 10.1186/s40425-019-0579-z
203 rdf:type schema:PropertyValue
204 Ne4bc6a11529f4c219f25e905bb0b87e1 rdf:first Neebcb4bb8af14dd99072eac2acf804db
205 rdf:rest N4ec432aedd0945a8a4c39191bc55d519
206 Neebcb4bb8af14dd99072eac2acf804db schema:affiliation N05776e345c59462ca6ceb8ef941cb4f6
207 schema:familyName Pazzola
208 schema:givenName Antonio
209 rdf:type schema:Person
210 Nf3216f7bb69b449299aa2ce5a0bc502d rdf:first Nc3e6412305de4204b09affda7ba94450
211 rdf:rest Nd0c4b0379ca647808311387df028379d
212 Nf9d04f1a691b4eaf8c2b182e4f594dc5 schema:affiliation https://www.grid.ac/institutes/grid.417011.2
213 schema:familyName Surico
214 schema:givenName Gianmarco
215 rdf:type schema:Person
216 Nff2abd3b9e674bf8a02f3774c20732eb schema:affiliation N3a74ef64e5a34d0fb0ec6a63c40940de
217 schema:familyName Cappuzzo
218 schema:givenName Federico
219 rdf:type schema:Person
220 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
221 schema:name Medical and Health Sciences
222 rdf:type schema:DefinedTerm
223 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
224 schema:name Oncology and Carcinogenesis
225 rdf:type schema:DefinedTerm
226 sg:journal.1049249 schema:issn 2051-1426
227 schema:name Journal for ImmunoTherapy of Cancer
228 rdf:type schema:Periodical
229 https://doi.org/10.1001/jamadermatol.2015.1916 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032824188
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1001/jamaoncol.2015.2274 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017475370
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1016/j.ejca.2015.11.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034148114
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1016/j.eururo.2017.02.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084074059
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1016/j.jtho.2017.08.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091880982
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1056/nejmoa1200690 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042896583
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1056/nejmoa1510665 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019970557
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1080/17425255.2016.1214713 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006340760
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1080/2162402x.2016.1231292 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058420756
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1093/annonc/mdw640 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059394941
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1097/cji.0000000000000046 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006229006
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1097/cji.0b013e318156e47e schema:sameAs https://app.dimensions.ai/details/publication/pub.1015171108
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1111/bju.14461 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105203453
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1158/1078-0432.ccr-07-0187 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049037424
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1158/1078-0432.ccr-15-1136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063224982
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1200/jco.2005.06.205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021025524
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1200/jco.2014.57.4756 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043986240
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1200/jco.2015.60.8448 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009760042
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1200/jco.2015.66.1389 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079388627
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1200/jco.2016.34.15_suppl.3047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106841583
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1200/jco.2017.77.6385 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101034912
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1212/wnl.0000000000004359 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091248943
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1371/journal.pone.0053745 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032246329
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1634/theoncologist.2017-0133 schema:sameAs https://app.dimensions.ai/details/publication/pub.1086386152
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1634/theoncologist.2017-0384 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105038826
278 rdf:type schema:CreativeWork
279 https://doi.org/10.3390/cancers10020032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100657075
280 rdf:type schema:CreativeWork
281 https://www.grid.ac/institutes/grid.410345.7 schema:alternateName Ospedale San Martino
282 schema:name Medical Oncology, San Martino Hospital, Genoa, Italy.
283 rdf:type schema:Organization
284 https://www.grid.ac/institutes/grid.411482.a schema:alternateName Ospedale di Parma
285 schema:name Medical Oncology, Azienda Ospedaliera di Parma, Parma, Italy.
286 rdf:type schema:Organization
287 https://www.grid.ac/institutes/grid.413172.2 schema:alternateName Ospedale Antonio Cardarelli
288 schema:name Oncology Unit, A. Cardarelli Hospital, Naples, Italy.
289 rdf:type schema:Organization
290 https://www.grid.ac/institutes/grid.413363.0 schema:alternateName Policlinico di Modena
291 schema:name Oncology and Hematology Department, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy.
292 rdf:type schema:Organization
293 https://www.grid.ac/institutes/grid.414614.2 schema:alternateName Ospedale Infermi di Rimini
294 schema:name Oncology, Ospedale Infermi, Rimini, Italy.
295 rdf:type schema:Organization
296 https://www.grid.ac/institutes/grid.415207.5 schema:alternateName Ospedale Santa Maria delle Croci
297 schema:name Medical Oncology, Ospedale Santa Maria delle Croci, Ravenna, Italy.
298 rdf:type schema:Organization
299 https://www.grid.ac/institutes/grid.416377.0 schema:alternateName Azienda Ospedaliera S.Maria
300 schema:name Medical Oncology, Azienda Ospedaliera Santa Maria, Terni, Italy.
301 rdf:type schema:Organization
302 https://www.grid.ac/institutes/grid.417007.5 schema:alternateName Policlinico Umberto I
303 schema:name Radiology, Oncology and Pathology, Policlinico Umberto I, Rome, Italy.
304 rdf:type schema:Organization
305 https://www.grid.ac/institutes/grid.417011.2 schema:alternateName Ospedale Vito Fazzi
306 schema:name Medical Oncology, Ospedale Vito Fazzi, Lecce, Italy.
307 rdf:type schema:Organization
308 https://www.grid.ac/institutes/grid.417520.5 schema:alternateName Istituti Fisioterapici Ospitalieri
309 schema:name Biostatistical Unit, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
310 Medical Oncology, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
311 rdf:type schema:Organization
312 https://www.grid.ac/institutes/grid.417893.0 schema:alternateName Istituto Nazionale dei Tumori
313 schema:name Medical Oncology-Genitourinary Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy.
314 Medical Oncology-Genitourinary Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy. elena.verzoni@istitutotumori.mi.it.
315 Urology and Gynecology, Istituto Nazionale Tumori - IRCCS - Fondazione Pascale, Naples, Italy.
316 rdf:type schema:Organization
317 https://www.grid.ac/institutes/grid.419450.d schema:alternateName Istituti Ospitalieri di Cremona
318 schema:name Medical Oncology, Istituti Ospitalieri di Cremona, Cremona, Italy.
319 rdf:type schema:Organization
320 https://www.grid.ac/institutes/grid.419563.c schema:alternateName Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
321 schema:name Urologic-Gynecologic Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola, Italy.
322 rdf:type schema:Organization
323 https://www.grid.ac/institutes/grid.8982.b schema:alternateName University of Pavia
324 schema:name Department of Internal Medicine, University of Pavia and Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.
325 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...